Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1940-0640
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Neurocognitive, psychiatric, and substance use characteristics in a diverse sample of persons with OUD who are starting methadone or buprenorphine/naloxone in opioid treatment programs ; volume:16 ; number:1 ; day:24 ; month:10 ; year:2021 ; pages:1-10 ; date:12.2021
Addiction science & clinical practice ; 16, Heft 1 (24.10.2021), 1-10, 12.2021
- Urheber
-
Scott, Travis M.
Arnsten, Julia
Olsen, James Patrick
Arias, Franchesca
Cunningham, Chinazo O.
Rivera Mindt, Monica
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13722-021-00272-4
- URN
-
urn:nbn:de:101:1-2022010418533694707631
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:34 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Scott, Travis M.
- Arnsten, Julia
- Olsen, James Patrick
- Arias, Franchesca
- Cunningham, Chinazo O.
- Rivera Mindt, Monica
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients
The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone
Methadone vs. buprenorphine/naloxone during early opioid substitution treatment: a naturalistic comparison of cognitive performance relative to healthy controls
A retrospective evaluation of patients switched from buprenorphine (subutex) to the buprenorphine/naloxone combination (suboxone)
Methadone, Buprenorphine, and Clonidine Attenuate Mitragynine Withdrawal in Rats
Budgetary impact analysis of buprenorphine-naloxone combination (Suboxone®) in Spain
Treatment retention in opioid agonist therapy: comparison of methadone versus buprenorphine/naloxone by analysis of daily-witnessed dispensed medication in a Canadian Province
Buprenorphine/naloxone versus methadone opioid rotation in patients with prescription opioid use disorder and chronic pain: study protocol for a randomized controlled trial
Healthcare provider perspectives on emergency department-initiated buprenorphine/naloxone: a qualitative study
Buprenorphine/naloxone – one formulation that doesn’t fit all: a case report
Perioperative opioid requirements of patients receiving sublingual buprenorphine-naloxone: a case series
The barriers to smoking cessation in Swiss methadone and buprenorphine-maintained patients